ketamine has been researched along with Myalgia in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Myalgia: Painful sensation in the muscles.
Excerpt | Relevance | Reference |
---|---|---|
"Ketamine seems to be an attractive alternative due to its rapid-onset antidepressant effects and impact on suicidal thoughts." | 3.01 | Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis. ( Cavalcanti, S; de A Simoes Moreira, D; Fonseca da Silva, AC; Gauer, LE; Quevedo, J; Teixeira, G, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
de A Simoes Moreira, D | 1 |
Gauer, LE | 1 |
Teixeira, G | 1 |
Fonseca da Silva, AC | 1 |
Cavalcanti, S | 1 |
Quevedo, J | 1 |
1 review available for ketamine and Myalgia
Article | Year |
---|---|
Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
Topics: Antidepressive Agents; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Ketamine; Myal | 2023 |